1,3-amino alcohols b-aminobicyclo[2.2.2]oct-5-ene-2-carboxylic acids
417
(R)-(1-Benzyloxycarbonylaminobicyclo[2.2.2]octane-2-
yl)methanol (15)
room temperature, concentration of the solvent and wash-
ings, the residue was purified by column chromatography
on silica gel, using dichloromethane/ethyl acetate (9/1) as
eluent to yield the expected compound (1S,2R,4R)-8 as a
Synthesized according to the general procedure from N-Z-
amino acid (R)-14 (100 mg, 0.33 mmol, 1 equiv) in THF
(4 ml), BOP reagent (145 mg, 0.33 mmol, 1 equiv), DIEA
(86 ll, 0.49 mmol, 1.5 equiv) and NaBH4 (37 mg,
0.99 mmol, 3 equiv). After stirring for 40 min at room
temperature, the residue obtained after treatment was
purified by column chromatography on silica gel, using
dichloromethane/ethyl acetate (9/1) as eluent to yield the
pure expected compound (R)-15 as a colourless oil (64 mg,
0.22 mmol, 65% yield); [a]2D0 = -37 (c = 1.5 in CH2Cl2);
tR (HPLC, column B) 2.0 min; MS (ESI) m/z 246.2 [(M-
colourless oil (99 mg, 0.35 mmol, 62% yield); [a]D20
=
-16 (c = 1.1 in CH2Cl2), tR (HPLC, column B) 2.19 min,
MS (ESI) m/z 244.3 [(M-CO2 ? H)?], 288.2 [(M ? H)?],
575.3 [(2 M ? H)?], 1H NMR (400 MHz, CDCl3, 25°C) d
0.63–0.79 (m, 1H, HCH), 1.25–1.36 (m, 1H, HCH),
1.39–1.54 (m, 2H 2HCH), 1.66–1.75 (m, 1H, HCH),
1.86–1.97 (m, 2H, HCH and CH-CH2-OH), 2.38–2.44 (m,
1H, 4-H), 2.62–2.46 (br s, 1H, OH), 3.20–3.42 (m, 2H,
CH2-OH), 4.97 (d, J = 12.5 Hz, 1H, OHCHC6H5), 5.02 (d,
J = 12.5 Hz, 1H, OHCHC6H5), 6.11–6.21 (m, 2H, 6-H
and 5-H), 6.26–6.42 (br s, 1H, NH), 7.18–7.26 (m, 5H, CH-
arom); 13C NMR (100 MHz, CDCl3, 25°C) d 24.2 (CH2),
28.5 (C-4), 29.9 (CH2), 30.9 (CH2), 42.5 (2-C), 56.3 (1-C),
64.8 (CH2OH), 65.2 (OCH2C6H5), 126.9, 127.1, 127.4
(CH-arom), 132.1 and 132.6 (CH=), 135.7 (C-arom), 154.8
(CO); HRMS (ESI) Calcd for C17H22NO3 (MH?)
288.1600, found 288.1599.
CO2 ? H)?], 290.3 [(M ? H)?], 312.1 [(M ? Na)?]; H
1
NMR (400 MHz, CDCl3, 25°C) d 1.16–1.21 (m, 1H,
HCH), 1.55–1.95 (2 m, 9H, 3CH2, 2HCH and 4-H),
2.10–2.18 (m, 2H, HCH and 2-H), 3.59 (dd, J = 5.1 and
11.1 Hz, 1H, HCH-OH), 3.78 (dd, J = 7.8 and 11.1 Hz,
1H, HCH-OH), 5.08 (s, 2H, OCH2C6H5), 7.28–7.36 (m,
5H, CH-arom); 13C NMR (100 MHz, CDCl3, 25°C) d 24.5
(4-C), 25.9 (CH2), 26.0 (CH2), 26.4 (CH2), 30.7 (CH2),
32.0 (CH2), 41.1 (2-C), 52.9 (1-C), 64.9 (CH2), 66.0 (CH2),
128.1, 128.2, 128.6 (CH-arom), 135.9 (C-arom), 155.4
(CO); HRMS (ESI) calculated for C17H24NO3 (MH?)
290.1756, found 290.1755.
(1R,2R,4S)-(1-Benzyloxycarbonylaminobicyclo[2.2.2]oct-
5-ene-2-yl)methanol (9)
Synthesized according to the general procedure from the
N-Z amino acid (1S,2R,4R)-6 (170 mg, 0.56 mmol, 1
equiv) in THF (4 ml) containing BOP reagent (255 mg,
0.56 mmol, 1 equiv), DIEA (0.15 ml, 0.85 mmol, 1.5
equiv) and NaBH4 (64 mg, 1.68 mmol, 3 equiv). After
stirring for 40 min at room temperature, the residue
obtained after treatment was purified by column chroma-
tography on silica gel, using dichloromethane/ethyl acetate
(9/1) as eluent to yield the expected compound (1S,2R,4R)-
9 as a colourless oil (108 mg, 0.38 mmol, 67% yield);
[a]2D0 = -46 (c = 1 in CH2Cl2), tR (HPLC, column A)
8.5 min, MS (ESI) m/z 288.4 [(M ? H)?], 1H NMR
(400 MHz, CDCl3, 25°C) d 0.72–0.86 (m, 1H, HCH),
1.28–1.45 (2 m, 2H, CH2), 1.48–1.58 (m, 1H, HCH),
1.60–1.78 (m, 2H, CH2), 1.80–1.95 (m, 1H, CH-CH2-OH),
2.02–2.30 (br s, 1H, OH), 2.34–2.42 (m, 1H, 4-H),
3.56–3.72 (m, 2H, CH2-OH), 4.97 (d, J = 12.5 Hz, 1H,
OHCHC6H5), 5.02 (d, J = 12.5 Hz, 1H, OHCHC6H5),
6.10 (dd, J = 6.7 and 8.3 Hz, 1H, 5-H), 6.42 (br d, 2H,
NH and 6-H), 7.18–7.32 (m, 5H, CH-arom); 13C NMR
(100 MHz, CDCl3, 25°C) d 24.7 (CH2), 26.4 (CH2), 29.3
(C-4), 30.4 (CH2), 41.4 (2-C), 56.5 (1-C), 64.8 (CH2OH),
66.2 (CH2C6H5), 127.9, 128.1, 128.4 (CH-arom), 131.4
(CH=), 136.9 (C-arom), 138.6 (CH=), 155.4 (CO); HRMS
(ESI) calculated for C17H22NO3 (MH?) 288.1600, found
288.1594.
(R)-(1-Butyloxycarbonylaminobicyclo[2.2.2]octane-2-
yl)methanol (17)
Synthesized according to the general procedure from N-Boc-
amino acid (R)-16 (100 mg, 0.37 mmol, 1 equiv) in THF
(4 ml), BOP reagent (145 mg, 0.33 mmol, 1 equiv), DIEA
(86 ll, 0.49 mmol, 1.5 equiv) and NaBH4 (37 mg,
0.99 mmol, 3 equiv). After stirring for 40 min at room tem-
perature, the residue obtained after treatment was purified by
column chromatography on silica gel, using cyclohexane/
ethyl acetate (7/3) as eluent to yield the pure expected
compound (R)-17 as a colourless oil (66 mg, 0.23 mmol,
62% yield); [a]2D0
=
-106 (c = 0.7 in CH2Cl2); MS
(ESI) m/z 156.2[(M-BOC ? H)?], 200.2 [(M-(CH2 =
C(CH3)2) ? H)?], 256.2 [(M ? H)?], 278.2 [(M ? Na)?];
1H NMR (400 MHz, CDCl3, 25°C) d 1.18–1.26 (m, 1H,
HCH), 1.41 (s, 9H, C(CH3)3), 1.51–1.82 (2 m, 8H, 2CH2,
3HCH and 4-H), 1.88–1.98 (m, 2H, 2HCH), 2.12–2.18 (m,
1H, 2-H), 3.58 (dd, J = 4.8 and 11.2 Hz, 1H, HCH-OH), 3.73
(dd, J = 7.2 and 11.2 Hz, 1H, HCH-OH); 13C NMR
(100 MHz, CDCl3, 25°C) d 23.9 (4-C), 25.3 (CH2), 25.8
(CH2), 26.0 (CH2), 26.5 (C(CH3)3), 27.9 (CH2), 30.2 (CH2),
40.9 (2-C), 51.9 (1-C), 64.6 (CH2), 78.5 (C(CH3)3), 128.1,
128.2, 128.6 (CH-arom), 154.9 (CO); HRMS (ESI) calculated
for C14H26NO3 (MH?) 256.1913, found 290.1919.
123